S
Songling Fu
Researcher at Zhejiang University
Publications - 25
Citations - 532
Songling Fu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Kawasaki disease & Endothelial stem cell. The author has an hindex of 10, co-authored 23 publications receiving 372 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Yujia Wang,Wei Wang,Fangqi Gong,Songling Fu,Qing Zhang,Jian Hu,Yan-qi Qi,Chunhong Xie,Yiying Zhang +8 more
TL;DR: Determination of the serum Th1/Th2 cytokine profile may be helpful for predicting the disease prognosis and targeting treatment strategies in patients with KD.
Journal ArticleDOI
Macrophage activation syndrome in Kawasaki disease: more common than we thought?
TL;DR: MAS may be a frequently under-recognized complication of KD, because the understanding of complications and diagnostic criteria are still in progress and the HLH 2009 criteria have low sensitivity and specificity.
Journal ArticleDOI
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
TL;DR: The white blood cell count, proportion of neutrophils, hemoglobin, CRP, ESR, albumin, NT-proBNP, interleukin-6 and 10 may be effective predictors for IVIG resistance and CALs in Kawasaki disease patients.
Journal ArticleDOI
MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies.
TL;DR: Both infant and maternal MTHFR C677T polymorphisms may contribute to the risk of CHDs, and the results varied across each subgroup in the stratified analysis of ethnicity and sample size.
Journal ArticleDOI
MiR-150-5p retards the progression of myocardial fibrosis by targeting EGR1
TL;DR: It is confirmed that sh-Egr1 would decrease the severity of MF, while miR-150-5p antagomir could aggravate MF, and EGR1 could influence the development of MF and provide a potential target for MF treatment.